References
- Kelts D G, Grand R J, Shen G, Watkins J B, Werlin S L, Boehme C. Nutritional basis of growth failure in children and adolescents with Crohn's disease. Gastroenterology 1979; 76: 720–7
- Leyden T, Rosenberg J, Nemchausky B, Elson C, Rosenberg I. Reversal of growth arrest in adolescents with Crohn's disease after parenteral alimentation. Gastroenterology 1976; 70: 1017–21
- Stokes M A. Crohn's disease and nutrition. Br J Surg 1992; 79: 391–4
- Underwood L E, Clemmons D R, Maes M, D'Ercole A J, Ketelslegers J M. Regulation of somatomedin C/insulin-like growth factor I by nutrients. Horm Res 1986; 24: 166–76
- Hawker F H, Stewart M P, Baxter R C. Relationship of somatomedin-C/insulin-like growth factor I levels to conventional nutritional indices in critically ill patients. Crit Care Med 1987; 15: 732–6
- Kirschner B S, Sutton M M. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 1986; 91: 830–6
- Christensen H, Jørgensen P H, Oxlund H, Laurberg S. Growth hormone increases the mass, the collagenous proteins, and the strength of rat colon. Scand J Gastroenterol 1990; 25: 1137–43
- Christensen H, Oxlund H, Laurberg S. Postoperative biosynthetic human growth hormone increases the strength and collagen deposition of experimental colon anastomoses. Int J Colorect Dis 1991; 6: 133–8
- Krawisz J E, Sharon P, Stenson W F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 1984; 87: 1344–50
- Wiedermann C J, Niedermühlbichler M, Beimpold H, Braunsteiner H. In vitro activation of neutrophils of the aged by recombinant human growth hormone. J Infect Dis 1991; 164: 1017–20
- Steinbeck M J, Roth J A. Neutrophil activation by recombinant cytokines. Rev Infect Dis 1989; 4: 549–68
- Morris G P, Beck P L, Herridge M S, Depew W T, Szewczuk M R, Wallace J L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795–803
- Wallace J L, Keenan C M. An orally active inhibitor of leukotrine synthesis accelerates healing in a rat model of colitis. Am J Physiol 1990; 258: G527–34
- Bradley P P, Priebat D A, Christensen R D, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78: 206–9
- Woessner J F. Determination of hydroxyproline in connective tissues. The methodology of connective tissue research, D A Hall. Joynson-Bruvvers, Oxford 1976; 227–33
- Flyvbjerg A, Ørskov H. Kidney tissue insulin-like growth factor I and initial renal growth in diabetic rats: relation to severity of diabetes. Acta Endocrinol (Copenh) 1990; 122: 374–8
- Ward H C, Halliday D, Sim A JW. Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg 1987; 206: 56–60
- Ziegler T R, Young L S, Ferrari-Baliviera E, Demling R H, Wilmore D W. Use of growth hormone combined with nutritional support in a critical care unit. J Parent Ent Nutr 1990; 14: 574–81
- Lobie P E, Breipohl W, Waters M J. Growth hormone receptor expression in the rat gastrointestinal tract. Endocrinology 1990; 126: 299–306
- Gupta S, Fikrig S M, Noval W S. Immunological studies in patients with isolated growth hormone deficiency. Clin Exp Immunol 1983; 54: 87–90
- Dahn M S, Mitchell R S, Smith S. Altered immunologic function and nitrogen metabolism associated with depression of plasma growth hormone. J Parent Ent Nutr 1984; 8: 690–4
- Keren D F. Autoreactivity and altered immune response in inflammatory bowel disease. Clin Lab Med 1988; 8: 325–36
- Harries A D, Danis V A, Heatley R V. Influence of nutritional status on immune functions in patients with Crohn's disease. Gut 1984; 25: 465–72
- Morin C L, Roulet M, Roy C C, Weber A, Lapointe N. Continuous elemental enteral alimentation in the treatment of children and adolescents with Crohn's disease. J Parent Ent Nutr 1982; 6: 194–9
- Gotlin R W, Dubois R S. Nyctohemeral growth hormone level in children with growth retardation and inflammatory bowel disease. Gut 1973; 14: 191–5
- Green J RB, O'Donoghue D P, Edwards C RW, Dawson A M. A case of apparent hypopituitarism complicating chronic inflammatory bowel disease in childhood and adolescence. Acta Paediatr Scand 1977; 66: 643–7
- McCaffery T D, Nasr K, Lawrence A M, Kirsner J B. Severe growth retardation in children with inflammatory bowel disease. Pediatrics 1970; 45: 386–91
- Abbassi V, Bellanti J A. Humoral and cell-mediated immunity in growth hormone-deficient children: effect of therapy with human growth hormone. Pediatr Res 1985; 19: 299–301
- Rapaport R, Oleske J, Ahdieh H, Solomon S, Delfaus C, Denny T. Suppression of immune function in growth hormone-deficient children during treatment with human growth hormone. J Pediatr 1986; 109: 434–9
- Herberman R B. Natural killer cell-mediated cytotoxicity. Manual of immunopathology, R Friedman. ASM Publications, Washington, DC 1985; 308–14
- Kelley K W. Growth hormone, lymphocytes and macrophages. Biochem Pharm 1989; 38: 705–13
- Fu Y K, Arkins B S, Wang B S, Kelley K W. A novel role of growth hormone and insulin-like growth factor-I. Priming neutrophils for superoxide anion secretion. J Immunol 1991; 146: 1602–8
- Alexander A C, Irving M H. Accumulation and pepsin solubility of collagens in the bowel of patients with Crohn's disease. Dis Colon Rectum 1990; 33: 956–62
- Durdey P, Switala S, Williams N S. Collagenolytic activity in Crohn's colitis. Br J Surg 1987; 74: 527
- Manson J, Wilmore D W. Growth hormone in the surgical patient. Growth hormone, L E Underwood. Marcel Dekker Inc., New York 1986; 255–67
- Arimura A, Smith W D, Schally A V. Blockade of the stress-induced decrease in blood GH by anti-somatostatin serum in rats. Endocrinology 1976; 98: 540–3